Kevin Hemphill

Kevin Hemphill is an experienced R&D Manager currently leading research and development initiatives at Revvity in the gene editing and modulation sector. Kevin previously held the same title at Horizon Discovery, where innovations in gene editing and modulation technologies were advanced. Kevin also contributed significantly as a Scientist II and Scientist I in Biology R&D roles at Horizon Discovery, focusing on new technologies and CRISPR products. Prior experience includes positions in viral manufacturing at Dharmacon, where Kevin developed standard operating procedures and launched various gene editing products. Kevin's academic background includes a Master’s Degree in Molecular Cellular and Developmental Biology from the University of Colorado Boulder and a Bachelor's Degree in Biochemistry from New Mexico State University.